186 related articles for article (PubMed ID: 10961766)
41. Clinical presentation of transformed migraine: possible differences among male and female patients.
Krymchantowski AV; Moreira PF
Cephalalgia; 2001 Jun; 21(5):558-66. PubMed ID: 11472382
[TBL] [Abstract][Full Text] [Related]
42. Relieving rebound headaches.
Towne LM
Nursing; 2007 Jun; 37(6):54. PubMed ID: 17538448
[No Abstract] [Full Text] [Related]
43. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five-year follow-up.
Schnider P; Aull S; Baumgartner C; Marterer A; Wöber C; Zeiler K; Wessely P
Cephalalgia; 1996 Nov; 16(7):481-5; discussion 461. PubMed ID: 8933992
[TBL] [Abstract][Full Text] [Related]
44. Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period.
Meskunas CA; Tepper SJ; Rapoport AM; Sheftell FD; Bigal ME
Headache; 2006 May; 46(5):766-72. PubMed ID: 16643579
[TBL] [Abstract][Full Text] [Related]
45. [Drug-induced headache].
Wallasch TM
Fortschr Neurol Psychiatr; 1992 Mar; 60(3):114-8. PubMed ID: 1349547
[TBL] [Abstract][Full Text] [Related]
46. Drug induced refractory headache--clinical features and management.
Mathew NT; Kurman R; Perez F
Headache; 1990 Oct; 30(10):634-8. PubMed ID: 2272811
[TBL] [Abstract][Full Text] [Related]
47. Effect of withdrawal of misused medication on sleep disturbances in migraine sufferers with chronic daily headache.
Hering-Hanit R; Yavetz A; Dagan Y
Headache; 2000; 40(10):809-12. PubMed ID: 11135024
[TBL] [Abstract][Full Text] [Related]
48. Probable medication-overuse headache: the effect of a 2-month drug-free period.
Zeeberg P; Olesen J; Jensen R
Neurology; 2006 Jun; 66(12):1894-8. PubMed ID: 16707727
[TBL] [Abstract][Full Text] [Related]
49. Medication-overuse headache in children: is initial preventive therapy necessary?
Kossoff EH; Mankad DN
J Child Neurol; 2006 Jan; 21(1):45-8. PubMed ID: 16551452
[TBL] [Abstract][Full Text] [Related]
50. [Drug dependence and withdrawal in chronic pain patients].
Wörz R
Fortschr Med; 1994 Jun; 112(16):229-31. PubMed ID: 8070745
[TBL] [Abstract][Full Text] [Related]
51. Topiramate for migraine prevention in a naturalistic setting: results from an open label, flexible dose study.
Nelles G; Delbrück A; Schulze L; Kademann B; Bornhoevd K; Schäfer S; Schäuble B;
Headache; 2009; 49(10):1454-65. PubMed ID: 19804392
[TBL] [Abstract][Full Text] [Related]
52. Treatment of chronic migraine: a 3-month comparator study of naproxen sodium vs SumaRT/Nap.
Cady R; Nett R; Dexter K; Freitag F; Beach ME; Manley HR
Headache; 2014 Jan; 54(1):80-93. PubMed ID: 24020994
[TBL] [Abstract][Full Text] [Related]
53. Management of medication overuse headache: 1-year randomized multicentre open-label trial.
Hagen K; Albretsen C; Vilming ST; Salvesen R; Grønning M; Helde G; Gravdahl G; Zwart JA; Stovner LJ
Cephalalgia; 2009 Feb; 29(2):221-32. PubMed ID: 18823363
[TBL] [Abstract][Full Text] [Related]
54. Breaking the cycle of medication overuse headache.
Tepper SJ; Tepper DE
Cleve Clin J Med; 2010 Apr; 77(4):236-42. PubMed ID: 20360117
[TBL] [Abstract][Full Text] [Related]
55. In-patient versus out-patient withdrawal programmes for medication overuse headache: a 2-year randomized trial.
Créac'h C; Frappe P; Cancade M; Laurent B; Peyron R; Demarquay G; Navez M
Cephalalgia; 2011 Aug; 31(11):1189-98. PubMed ID: 21700646
[TBL] [Abstract][Full Text] [Related]
56. Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine.
Fumal A; Laureys S; Di Clemente L; Boly M; Bohotin V; Vandenheede M; Coppola G; Salmon E; Kupers R; Schoenen J
Brain; 2006 Feb; 129(Pt 2):543-50. PubMed ID: 16330505
[TBL] [Abstract][Full Text] [Related]
57. Effect of valproic acid on withdrawal therapy in patients with overuse of chronic daily headache medications.
Coskun O; Ucler S; Cavdar L; Inan LE
J Clin Neurosci; 2007 Apr; 14(4):334-9. PubMed ID: 16647854
[TBL] [Abstract][Full Text] [Related]
58. Chronic headaches: pharmacological and non-pharmacological treatment.
Grazzi L; Usai S; Bussone G
Neurol Sci; 2007 May; 28 Suppl 2():S134-7. PubMed ID: 17508160
[TBL] [Abstract][Full Text] [Related]
59. Use and overuse of antimigraine drugs by pharmacy personnel in France: COTA survey.
Donnet A; Lantéri-Minet M; Aucoin F; Allaf B
Headache; 2009 Jul; 49(7):1014-21. PubMed ID: 19486362
[TBL] [Abstract][Full Text] [Related]
60. Duloxetine prophylaxis for episodic migraine in persons without depression: a prospective study.
Young WB; Bradley KC; Anjum MW; Gebeline-Myers C
Headache; 2013 Oct; 53(9):1430-7. PubMed ID: 24032526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
